09
11 月 22
2nd CEO Meeting (2022-24)
Over 20 CEOs and directors from our member companies joined the 2nd CEO Meeting of the term (2022-24) held online on 9 November 2022.
07
10 月 22
特別會員大會2022
An online EGM was called by the HKAPI Board to pass a resolution to adopt the new Code of Practice. It was unanimously adopted by members with immediate effect.
06
9 月 22
31
8 月 22
11
7 月 22
2022-24年度第一次CEO會議
本年度(2022-24)第一次CEO會議，已於2022年7月11日順利於網上舉行。逾20名來自會員公司的高級管理人員參與其中，與本屆新成立的董事會成員會面，並一同商討本會未來發展方向。
07
7 月 22
活動提要：The Journey of Biotech Innovation and Investment in Hong Kong
香港科研製藥聯會非常榮幸成為投資推廣署活動「The Journey of Biotech Innovation and Investment in Hong Kong」的支持機構，與生物醫藥界、投資公司及學術界等代表交流對香港醫藥創科發展及投資的見解。
02
6 月 22
應對抗菌素耐藥性
The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment...
28
4 月 22
工作小組分享會：藥業界與地區康健中心及社區藥房的合作
為幫助會員了解基層醫療服務的運作，以及地區康健中心、社區藥房逐步發展為藥業界帶來的機遇，本會公私營協作工作小組於2022年4月27日舉辦了一場分享會。
22
4 月 22